MCP
CELG

Mirador Capital Partners’s Celgene Corp CELG Stock Holding History

Mirador Capital Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,403
Closed -$1.11M – 162
2018
Q3 		$1.11M Buy
12,403
+481
+4% +$42.5K 0.54% 63
2018
Q2 		$947K Sell
11,922
-45
-0.4% -$3.74K 0.52% 60
2018
Q1 		$1.04M Buy
+11,967
New +$1.15M 0.73% 44

Other funds holding CELG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mirador Capital Partners's CELG Position: Q4 2018 in Review

Mirador Capital Partners sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 12,403 shares — an estimated $1.11M sold.

Mirador Capital Partners first reported a position in CELG in Q1 2018 and held it in 3 quarters. The position peaked at $1.11M in Q3 2018. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Mirador Capital Partners reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Mirador Capital Partners sold 12,403 Celgene Corp shares in Q4 2018, an estimated $1.11M.
  • Mirador Capital Partners first reported a position in Celgene Corp in Q1 2018 and held it in 3 quarters.
  • Mirador Capital Partners's Celgene Corp position peaked at $1.11M in Q3 2018.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Mirador Capital Partners's 13F filing for Q4 2018, filed 13 Feb 2019.